MAASTRICHT, Netherlands, June 29 /PRNewswire/ --
- The first and only guaranteed ultrasound probe repair solution makes efficient use of shrinking healthcare budgets
MEDRAD, INC., Multi Vendor Service has extended TotalRepair, the first and only guaranteed ultrasound probe repair solution, to European markets. Enabled by 100 percent repair capabilities, TotalRepair allows healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair.
MVS is committed to developing new repair techniques that will make equipment service budgets go farther. This has incredible value to healthcare systems during grueling economic times like these, said Diane Watson, executive director of MEDRAD Multi Vendor Service. With ever-increasing repair capabilities and new offerings like TotalRepair, MVS can help hospitals and imaging centers save money by extending the life of their equipment.
TotalRepair not only helps healthcare facilities reduce service costs, but also mitigate financial exposure with a capped, guaranteed worst case scenario price provided up front. For a complete listing of probes that are eligible for TotalRepair in Europe, please contact MVS Inside Sales at email@example.com.
Multi Vendor Service, as a part of the MEDRAD Service business, provides third-party service on ultrasound transducers, parts, MRI coils and imaging product services. For more information about MEDRAD MVS, visit www.medrad.com/mvs.
About MEDRAD, Inc.
MEDRAD, Inc. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Carmen Silverstandt of MEDRAD MVS, +31-43-3585698, firstname.lastname@example.org, or Luanne Radermacher of MEDRAD, +1-724-940-7968, email@example.com; Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO